Publication

Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration.

Journal Paper/Review - Oct 14, 2022

Units
PubMed
Doi
Contact

Citation
Altersberger V, Rusche N, Martinez-Majander N, Hametner C, Scheitz J, Hénon H, Dell'Acqua M, Strambo D, Stolp J, Heldner M, Grisendi I, Jovanovic D, Béjot Y, Pezzini A, Leker R, Kägi G, Wegener S, Cereda C, Lindgren E, Ntaios G, Piot I, Polymeris A, Lyrer P, Räty S, Sibolt G, Tiainen M, Heyse M, Erdur H, Kaaouana O, Padjen V, Zedde M, Arnold M, Nederkoorn P, Michel P, Bigliardi G, Zini A, Cordonnier C, Nolte C, Ringleb P, Curtze S, Engelter S, Gensicke H, Thrombolysis in Stroke Patients (TRISP) Collaborators. Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration. Stroke 2022; 53:3557-3563.
Type
Journal Paper/Review (English)
Journal
Stroke 2022; 53
Publication Date
Oct 14, 2022
Issn Electronic
1524-4628
Pages
3557-3563
Brief description/objective

The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely influence individual IVT treatment decisions. Using data from a large IVT registry, we aimed to provide more evidence on safety of IVT in the very elderly.